MediWound
MDWD
64 hedge funds and large institutions have $66.6M invested in MediWound in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 9 closing their positions.
350% more call options, than puts
Call options by funds: $306K | Put options by funds: $68K
39% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 18
0% more funds holding
Funds holding: 64 → 64 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
2.95% less ownership
Funds ownership: 41.09% → 38.13% (-3%)
16% less capital invested
Capital invested by funds: $79M → $66.6M (-$12.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.86M |
| 2 |
BlackRock
New York
|
+$675K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$318K |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$228K |
| 5 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
+$216K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$2.17M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1.35M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.08M |
| 4 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$939K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$821K |
MDWD Hedge Fund Activity: Q1 2025 in Review
64 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q1 2025, worth a combined $66.6M — down 16% from $79M a quarter earlier.
Fund positioning in MDWD was balanced in Q1 2025: 9 funds opened new positions, 9 closed out, 25 added to existing stakes and 18 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $2.86M. The largest seller was Rosalind Advisors, cutting an estimated $2.17M.
- 64 institutional investors held MediWound (MDWD) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $66.6M of MediWound stock for Q1 2025, down 16% quarter-over-quarter.
- 9 funds opened new MediWound positions in Q1 2025 and 9 closed out, a net change of 0 holders.
- The largest MediWound buyer in Q1 2025 was T. Rowe Price Associates, an estimated $2.86M added.
- The largest MediWound seller in Q1 2025 was Rosalind Advisors, an estimated $2.17M sold.
Based on aggregated 13F filings for Q1 2025.